METHOCEL™ Premium DC2 Cellulose Ethers
Available as directly compressible grades, METHOCEL™ DC2 polymers deliver exceptional flow properties and process capability as well as consistent modified release performance for matrix formulations. METHOCEL™ DC2 enable manufacturers to replace costly wet granulation in matrix tablet production with cost effective dry granulation and direct compression techniques.
METHOCEL™ DC2 helps you enjoy the benefits of dry powder processing techniques:
- improved powder flow
- lower manufacturing costs by up to 60%
- shorten development time
- results in more reproducible and robust tablet properties
- better formulation option for heat and moisture-sensitive APIs
- no additives, means no regulatory hurdles, as METHOCEL™ DC2 is pure HPMC
Two direct compression grades of METHOCEL™ DC2 are available: K100 LV, and K100M; chemically identical to current METHOCEL™ Premium products and meet USP, PhEur and JP specifications.
Colorcon, through the Controlled Release Alliance, has exclusive, global sales and distribution rights for METHOCEL™ products from IFF for use in controlled release applications.
METHOCEL™ is a trademark of International Flavors and Fragrances Inc. or its affiliates. © 2021 IFF. All rights reserved
Platform Solutions
Colorcon can help to reduce your project time by providing the right solution through excipient selection and process guidance.
Productivity
Lower total cost and reduce time to market
Dissolution Design
Life cycle management through modified delivery profiles and product line extensions
Patient Adherence
Reduce medication errors and improve patient adherence
Stability
Stable and consistent product performance
Product Authentication
Track and trace
